ResMed (RMD) Stock Price Today & Analysis
RMD
Valuation
Market cap$38.05B
Price-to-sales ratio7.21
Price-to-book value6.19
Price-earnings ratio26.30
Return on Equity25.00%
Return on Sales0.33%
Return on Assets0.18%
PEG ratioN/A
Earnings Per Share
Earnings Per Share$9.81
Income Statement
Average volume921,547
EBITDA$1.97B
1 year high (52w)$293.81
1 year low (52w)$199.92
Dividend
Dividend yield0.87%
Solvency
Debt-to-equity ratioN/A
About ResMed
Resmed pioneers innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Their digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. By enabling better care, they improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.
FAQ
You can easily purchase ResMed (RMD) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'RMD' ticker to begin your investment journey.
At Gotrade, you can kickstart your investment in ResMed with as little as $1.
Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).
Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.
